Cor Vasa 2010, 52(3):188-192 | DOI: 10.33678/cor.2010.047
Amyloidosis as a rare cause of dyspnea
- 1 I. interní klinika
- 2 III. interní klinika Fakultní nemocnice Olomouc a Lékařské fakulty Univerzity Palackého v Olomouci, Česká republika
We report the case of a 44-year-old man examined for dyspnea lasting several months with manifestations of heart failure. The patient developed the dyspnea after a protracted febrile condition. An electrocardiogram showing a scar on the anterior wall and left ventricular dysfunction with a 40% left ventricular ejection fraction (LVEF) and mild pericardial exudates led initially to suspected coronary heart disease ruled out by a negative coronary angiogram. Marked left ventricular hypertrophy on follow-up echocardiography and the finding of nephritic proteinuria made us consider a systemic disease. Heart magnetic resonance imaging excluded previous myocarditis and late subendocardial enhancement together with the detection of serum and urinary paraprotein, and a non-proportional increase in lambda free light chains, established the diagnosis of primary amyloidosis (AL) confirmed by biopsy. There was regression of signs of left-heart failure following titration of doses of a beta-blocker, ACE inhibitor and diuretics. The patient has been scheduled for chemotherapy in the ensuing months.
Keywords: Amyloidosis; Cardiomyopathy; Hypertrophy; Heart Failure
Published: March 1, 2010 Show citation
References
- Hess OM, McKenna W, Schultheiss HP, et al. Myocardial Disease. In: Camm AJ, Lüscher TF, Serruys PW, et al. The ESC textbook of cardiovascular medicine. Oxford: Blackwell Publishing, 2006:478-479.
- Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91:141-157.
Go to original source...
Go to PubMed...
- Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-555.
Go to original source...
- Feng D, Edwards WD, Oh JK, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 2007;116:2420-2426.
Go to original source...
- Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005;95:535-537.
Go to original source...
- Dispenzieri A, Kyla RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003;361: 1787-1789.
Go to original source...
- Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;16:1135-1141.
Go to original source...
- Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation 1981;63:1285-1288.
Go to original source...
- Gertz MA, Skinner M, Connors LH, et al. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol 1985;55(13 Pt 1):1646.
Go to original source...
- Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 1993;104:618-620.
Go to original source...
Go to PubMed...
- Kristen, AV, Dengler, TJ, Hegenbart, U, et al. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm 2008;5:235-240.
Go to original source...
Go to PubMed...
- Palladini, G, Campana, C, Klersy, C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440-2445.
Go to original source...
Go to PubMed...
- Ng B, Connors LH, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005; 165:1425-1429.
Go to original source...
Go to PubMed...